An interventional study of Universal meal coefficient utilization in Type1diabetes, sponsored by Tartu University Hospital. Recruiting at 1 site in Estonia. Open to participants aged 7 Years to 19 Years. Per ClinicalTrials.gov, last updated 2024-04-18.
Sponsored by Tartu University Hospital · Not applicable, Interventional, and Treatment
Cross-over study of 20 pediatric patients (age 7-19) randomized to the group receiving universal fixed meal boluses coefficients (300/TDD for breakfast and 400/TDD other meal) or to the group with individualized coefficients for the period of 14 days with consecutive analysis of the results from Carelink Raport.
3,522 studies on the registry are indexed under Diabetes Mellitus, Type 1; 577 are open to participants now.
This study's planned enrollment of 20 is below the median of 40 across 2,649 interventional studies indexed under Diabetes Mellitus, Type 1.
Browse Diabetes Mellitus, Type 1 studies →Tartu University Hospital is the lead sponsor of 24 studies on the registry; 10 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
With fixed meal bolus coefficients (TDD/300 breakfast and TDD/400 other meals)
Device: Universal meal coefficient utilization
With meal bolus coefficient individualized according to physician judgment's
Device: Universal meal coefficient utilization
Usage of universal fixed meal bolus coefficients for the control of postprandial hyperglycemia compared to individualized coefficients n the users of Medtronic Minimed 780G pumps
Time in range (TIR)
Comparision of TIR between groups
Time frame: 4 weeks
TBR
Comparision of TBR between groups
Time frame: 4 weeks
TAR
Comparision of TAR between groups
Time frame: 4 weeks
auto-corrections %
auto-corrections % between groups
Time frame: 4 weeks
coefficient of variability
coefficient of variability between groups
Time frame: 4 weeks
Plan to share: No
No publications or documents are linked to this record.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Tartu University Hospital